Rivaroxaban for the treatment of cerebral venous thrombosis: a single-center experience

The mainstay of cerebral venous thrombosis (CVT) treatment according to current guidelines is parenteral anticoagulation with unfractionated heparin or low-molecular-weight heparin followed by long-term oral anticoagulation with vitamin K antagonists. Direct oral anticoagulants (DOACs), including th...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Acta neurologica Belgica 2022-02, Vol.122 (1), p.105-111
Hauptverfasser:	Bajko, Zoltan, Maier, Smaranda, Motataianu, Anca, Filep, Rares Cristian, Stoian, Adina, Andone, Sebastian, Balasa, Rodica
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomedical and Life Sciences Biomedicine Medicine/Public Health Neurology Neuroradiology Neurosciences Original Article
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!